Our data revealed that CAFs with reduced GATA6/TET1 exhibited decreased secretion of IL-6, VEGF, and TGF-β (p < 0.05 vs. Control 1; Fig. 3B), critical mediators of angiogenesis and tumor-stroma crosstalk. This evidence concerns the gene IL6 and neoplasm.